Form 4: Quest Diagnostics SVP Patrick Plewman Reports Stock Acquisition and Holdings

Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, reports acquiring 60 shares of common stock through a dividend reinvestment plan and discloses total holdings.

Summary

• Patrick Plewman, a Senior Vice President at Quest Diagnostics, filed a Form 4 with the SEC.
• The form reports a transaction on October 21, 2024, where Mr. Plewman acquired 60 shares of Quest Diagnostics common stock through a dividend reinvestment plan at a price of $149.37 per share.
• Mr. Plewman's total holdings after the reported transaction amount to 16,258 shares of Quest Diagnostics common stock, including exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an insider. The acquisition of shares through a dividend reinvestment plan could be seen as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of shares through a dividend reinvestment plan indicates confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Key Dates